info:eu-repo/semantics/article
Successful GPi stimulation in genetic Parkinson’s disease caused by mosaicism of alpha-synuclein gene duplication: first description
Fecha
2014-11Registro en:
Perandones, Claudia; Aráoz Olivos, Natalia Silvana; Raina, G. B.; Pellene, L. A.; Giugni, J. C.; et al.; Successful GPi stimulation in genetic Parkinson’s disease caused by mosaicism of alpha-synuclein gene duplication: first description; Springer; Journal Of Neurology; 262; 1; 11-2014; 222-223
0340-5354
CONICET Digital
CONICET
Autor
Perandones, Claudia
Aráoz Olivos, Natalia Silvana
Raina, G. B.
Pellene, L. A.
Giugni, J. C.
Calvo, D. S.
Radrizzani Helguera, Martin
Piedimonte, F.
Micheli, F. E.
Resumen
DBS is an established therapy for advanced PD [1] and has been reported to be efficacious in a few patients with monogenic parkinsonisms such as LRRK2, Parkin, and PINK1 [2–6]. By contrast, knowledge about the outcome of DBS in patients with SNCA mutations is scarce, since only one case has been reported to date